GNRH2 Polymorphism in Men With Prostate Cancer Treated With Androgen Deprivation Therapy.

Tristan M SissungSarah LochrinTyler LiuKeith SchmidtJonathan StropeEmily RisdonHyoyoung Choo-WosobaDavid J VenzonWiem LassouedHoussein A SaterBeatriz Walter-RodriguezDouglas K PriceWilliam D Figg

Published in: Anticancer research (2023)

GNRH2 is expressed in normal, hyperplastic, and neoplastic prostate tissues; the A16V variant is not related to treatment outcome or survival.

Keyphrases

prostate cancer
radical prostatectomy
gene expression
free survival
benign prostatic hyperplasia
mesenchymal stem cells